* Information available to verified or subscribed users. The first stage in this process is to Register - please
click here to Register.
If you have already Registered, please click here to login.
|
| Page No 1 2 3 4 5 |
| Phrase | Consultant | Town | Special Interests |
| stereotactic radiotherapy and radiosurgery | *Consultant(s)* | *Towns* | Clinical oncology, neuro-oncology, lung cancer, meningioma, stereotactic radiotherapy and radiosurgery, glioma, acoustic neuroma, glioblastoma |
| stereotactic radiotherapy for lung cancer | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, stereotactic radiotherapy for lung cancer, urological oncology |
| stereotactic radiotherapy for lung tumours | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, stereotactic radiotherapy for lung tumours, breast cancer |
| stereotactic radiotherapy/surgery | *Consultant(s)* | *Towns* | Clinical oncology, neuro-oncology, paediatric radiotherapy, stereotactic radiotherapy/surgery |
| storage of reproductive function prior to chemotherapy and radiotherapy | *Consultant(s)* | *Towns* | Gynaecological endocrinology, menorrhagia, menopause, infertility, assisted conception and related surgery, storage of reproductive function prior to chemotherapy and radiotherapy, factors affecting growth and development, implantation of embryos, benign gynaecology |
| TARGIT intraoperative radiotherapy | *Consultant(s)* | *Towns* | Surgical oncology, breast cancer and breast diseases, intraoperative radiotherapy, tobacco eradication, screening for breast cancer, TARGIT intraoperative radiotherapy, familial risk and genetic breast cancer, HRT - hormone replacement therapy, lumpectomy surgery, mastectomy, sentinal node biopsy and axillary clearance, neoadjuvant chemotherapy |
| technical radiotherapy | *Consultant(s)* | *Towns* | Clinical oncology, guided radiotherapy, urological oncology, prostate brachytherapy, lung cancer, technical radiotherapy |
| treatment response in HPV - human papilloma virus +ve oropharyngeal cancer intraoperative radiotherapy | *Consultant(s)* | *Towns* | Early phase clinical trials, the role of the p53/MDM2 pathway in radioresistance and cellular motility, the therapeutic exploitation of the unfolded protein response in head and neck cancer, treatment response in HPV - human papilloma virus +ve oropharyngeal cancer intraoperative radiotherapy, core and swallowing outcomes in late phase clinical trials involving patients with OPSCC - oropharyngeal squamous cell carcinoma, function sparing surgical strategies for head and neck cancer - especially transoral laser microsurgery |
| Page No 1 2 3 4 5 |
|
|
|
|
